Literature DB >> 28922210

Screening for DSM-5 Somatic Symptom Disorder: Diagnostic Accuracy of Self-Report Measures Within a Population Sample.

Johannes A C Laferton1, Nikola M Stenzel, Winfried Rief, Kristina Klaus, Elmar Brähler, Ricarda Mewes.   

Abstract

OBJECTIVE: The new DSM-5 somatic symptom disorder was introduced to improve the diagnosis of persons experiencing what used to be called somatoform disorders. So far, it is unclear whether existing self-report measures are useful to detect the new somatic symptom disorder. This study investigates the diagnostic accuracy of three self-report questionnaires that measure somatic complaints (15 item Patient Health Questionnaire [PHQ-15]) and psychological features (7-item Whiteley Index [WI-7]; Scale for Assessing Illness Behavior [SAIB]), in detecting somatic symptom disorder.
METHODS: A nationally representative general population survey was performed resulting in 250 participants (minimum age = 14 years. 12.8% participation rate). Assessment took place at baseline and 12-month follow-up. Individual and combined diagnostic accuracy of the PHQ-15, WI-7, and SAIB in detecting somatic symptom disorder was evaluated using the area under the curve (AUC) of a receiver operating characteristic.
RESULTS: Diagnostic accuracy was adequate to good for each individual questionnaire (PHQ-15: AUC = 0.79, p < .001, 95% confidence interval [CI] = 0.73-0.85; WI-7: AUC = 0.76, p < .001, 95% CI = 0.69-0.83; SAIB: AUC = 0.77, p < .001, 95% CI = 0.71-0.83). Combining the PHQ-15 and the WI-7 slightly improved diagnostic accuracy (AUC = 0.82, p < .001, 95% CI = 0.77-0.88), as did the combination of all three questionnaires (AUC = 0.85, p < .001, 95% CI = 0.79-0.90).
CONCLUSIONS: The PHQ-15, WI-7, and SAIB are useful screening instruments to detect persons at risk for somatic symptom disorder, and a combination of these three instruments slightly improves diagnostic accuracy. Their use in routine care will lead to improved detection rates.

Entities:  

Mesh:

Year:  2017        PMID: 28922210     DOI: 10.1097/PSY.0000000000000530

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  6 in total

1.  Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Joel S Perlmutter; Kelvin L Chou; Julie C Stout; Jane S Paulsen; Michael K McCormack; David Cella; Martha A Nance; Jin-Shei Lai; Praveen Dayalu
Journal:  J Neurol       Date:  2018-04-23       Impact factor: 4.849

2.  Research on Somatization and Somatic Symptom Disorders: Ars longa, vita brevis.

Authors:  Joel E Dimsdale
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

3.  Identifying and measuring the severity of somatic symptom disorder using the Self-reported Somatic Symptom Scale-China (SSS-CN): a research protocol for a diagnostic study.

Authors:  Meng Jiang; Weituo Zhang; Xuan Su; Chuang Gao; Bingxu Chen; Zehao Feng; Jialiang Mao; Jun Pu
Journal:  BMJ Open       Date:  2019-09-26       Impact factor: 2.692

4.  Psychometric Properties of the Chinese Version of the Cognitions About Body and Health Questionnaire.

Authors:  Shih-Cheng Liao; Wei-Lieh Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-21       Impact factor: 2.570

5.  Psychometric Evaluation of the Whiteley Index-8 in Chinese Outpatients in General Hospitals.

Authors:  Yixiao Chen; Per Fink; Jing Wei; Anne-Kristin Toussaint; Lan Zhang; Yaoyin Zhang; Hua Chen; Xiquan Ma; Wentian Li; Jie Ren; Wei Lu; Rainer Leonhart; Kurt Fritzsche; Heng Wu
Journal:  Front Psychol       Date:  2021-07-01

6.  Efficacy of a guided internet-based intervention (iSOMA) for somatic symptoms and related distress in university students: study protocol of a randomised controlled trial.

Authors:  Severin Hennemann; Katja Böhme; Harald Baumeister; Eileen Bendig; Maria Kleinstäuber; David Daniel Ebert; Michael Witthöft
Journal:  BMJ Open       Date:  2018-12-31       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.